Latest Innosphere Fund News
Nov 30, 2020
Innosphere Ventures’ Fund makes investment into a company focused on novel wound healing solutions | Source: Innosphere Ventures photo-release GelSana Therapeutics has designed and developed novel wound dressing gels that provide superior healing to patients. The company’s hydrogel systems offer unique wound healing properties that accelerate wound closure, generate strong epidermal layers post healing, and enable controlled delivery of therapeutics that could benefit certain types of wounds. Innosphere Ventures accelerates the success of science and technology startups and emerging growth companies with office and laboratory facilities, a seed stage venture capital fund, and an exclusive commercialization program.The Innosphere Ventures Fund is a seed-stage venture capital fund that leads seed-stage investment rounds in companies that are likely to achieve a near-term exit through a corporate acquisition. As Colorado’s leading incubation program and commercialization expert, Innosphere focuses on ensuring companies are investor-ready, connecting founders with experienced advisors and early hires, making introductions to corporate partners, exit planning, and accelerating top line revenue growth. Innosphere has been supporting startups for over 20 years and is a non-profit 501(c)(3) organization with a strong mission to create jobs and grow Colorado’s entrepreneurship ecosystem. Golden and Fort Collins, CO, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Innosphere Ventures , Colorado’s commercialization program and seed-stage venture capital fund, has announced their investment in GelSana Therapeutics (GelSana), a startup company developing novel hydrogels that improve wound healing for diabetic ulcers and other wounds. GelSana will use the Innosphere Ventures Fund investment to accelerate their product development plan. This is the first time Innosphere Ventures has invested in a technology being developed at Colorado School of Mines . “Innosphere has a long-standing partnership with the Colorado School of Mines Office of Research and Technology Transfer and we’re excited to contribute to the growth of Melissa Krebs’ technology and company,” said Mike Freeman, Innosphere Ventures CEO and general partner who led the investment into GelSana. “Professor Krebs is an exceptional CEO and the kind of technical founder you want to invest in.” “Our products have shown they can significantly increase the number of patients that can completely heal their wounds,” said Melissa Krebs, founder and CEO of GelSana and Associate Professor at Colorado School of Mines. “We started this company with a focus on resolving diabetic foot ulcers which pose serious health and financial burdens to those affected but believe the unique properties of our hydrogels may have broader applicability in wound healing.” For more information on Innosphere Ventures and this investment, contact Mike Freeman, General Partner of the Innosphere Fund, at email@example.com or (970) 817-4791. Attachments
Innosphere Fund Team
2 Team Members
Innosphere Fund has 2 team members, including current General Partner, Mike Freeman.